16 Feb 2016 07:00
Tuesday 16 February 2016
Dechra® Pharmaceuticals PLC
(Dechra, Company or the Group)
Directorate update
Dechra announces that the Chief Financial Officer, Anne-Francoise Nesmes, will be stepping down from the Board of Dechra and leaving the business on 31 July 2016 in order to take up the role of Chief Financial Officer at Merlin Entertainments plc.
On behalf of the Board, colleagues and shareholders at Dechra we would like to congratulate Anne-Francoise on this exciting opportunity and wish her well for the future.
Mike Redmond, Chairman, commented:
"Anne-Francoise joined Dechra in 2013 from GSK, and during her tenure, she has developed the financial strategy of the Group and introduced efficient tax and treasury solutions, accelerating the development of the finance function; she has recruited talented individuals strengthening our expertise and creating a knowledgeable team of people across the business. Having strength and depth in our finance organisation puts Dechra in a great position to support its growth strategy."
Ian Page, Chief Executive Officer, said:
"During her career, Anne-Francoise has developed her experience in a variety of roles and, as a high calibre finance professional, I and my colleagues have welcomed her enthusiasm, knowledge and energy. I personally thank her for her support in progressing our strategy of delivering a high growth, cash generative, specialist veterinary products business."
Anne-Francoise Nesmes, Chief Financial Officer, added:
"I have enjoyed my time at Dechra as I joined at an exciting time when the Company accelerated its growth, expanded internationally and focused on becoming a pure pharmaceutical player. I will leave Dechra in a strong position and I wish the team well in the future development of the business."
The Board has commenced the process to recruit a replacement and details will be announced in due course.
Enquiries: | |
Dechra Pharmaceuticals PLC | |
Mike Redmond, Chairman | Office: +44 (0) 1606 814 730 |
Ian Page, Chief Executive Officer | Mobile: +44 (0) 7775 642 222 |
Anne-Francoise Nesmes, Chief Financial Officer e-mail: corporate.enquiries@dechra.com | |
TooleyStreet Communications Ltd | |
Fiona Tooley, Director e-mail: fiona@tooleystreet.com | Mobile: +44 (0) 7785 703 523 |
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and relates products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.
For more information please visit: www.dechra.com
Stock Code: Full Listing (Pharmaceuticals): DPH
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.